(ANSA) – ROME, SEPTEMBER 04 – The Moderna company has announced that it has submitted data for conditional marketing approval (CMA) to the European Medicines Agency (EMA) for the evaluation of a dose of 50 μg for the booster (third dose) of the Modern COVID-19 vaccine (mRNA-1273). The company communicates this in a note. (HANDLE).
REPRODUCTION RESERVED © Copyright ANSA
Get the embed code